Status:
RECRUITING
Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Acetabular Labrum Tear
Femoro Acetabular Impingement
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to...
Detailed Description
1. Background Surgical management of labral pathology has evolved to reflect our current understanding of mechanism of injury and resulting hip dysfunction. Correction of labral pathology presents a t...
Eligibility Criteria
Inclusion
- Age: \> or equal to 18 years
- Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology
- Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand \& sign the informed consent document
Exclusion
- Non-English speaking (PROM surveys are only validated in English)
- Prior same site (i.e., ipsilateral hip) surgery, including but not limited to previous hip arthroscopy, core decompression, or periacetabular osteotomies
Key Trial Info
Start Date :
August 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2045
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06003101
Start Date
August 30 2023
End Date
August 30 2045
Last Update
November 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114